Description

Speakers will provide insights on the current stage of deployment of CM for biological molecule clinical manufacturing from the point of view of process technologies, facility assets, and manufacturing operations. Examples of successes as well as challenges encountered will be shared.

Moderator(s):

• Antonio Moreira, PhD, Vice Provost, Academic Affairs, University of Maryland, Baltimore County

Speaker(s):

• Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca
• Mark Brower, Principal Scientist, Merck & Co., Inc.
• Govind Rao, PhD, Professor & Director, Center for Advanced Sensor Technology, University of Maryland, Baltimore County